RECURSION PHARMACEUTICALS, INC. (RXRX) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading RXRX…

RECURSION PHARMACEUTICALS, INC. (RXRX) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

RECURSION PHARMACEUTICALS, INC.

RXRX · CIK 1601830

4 · Sep 10, 2026 · Director, CEO and President Khan Najat sold 22.41K shares at $3.52/share ($78,822)

4

Director, CEO and President Khan Najat sold 22.41K shares at $3.52/share ($78,822)

Filed: Sep 10, 2026
Period: Sep 8, 2026
Accession: 0001601830-26-000105
Filer: RECURSION PHARMACEUTICALS, INC.

View on SEC.gov All SEC filings

Filing document

FORM 4

xslF345X06/wk-form4_1789077354.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4FORM 4wk-form4_1789077354.xml
Open SEC.gov